It may reduce the risk by acting as an inhibiting factor towards viral infections [31], e.g., by downregulating ACE2 in the nasal epithelium [32] and subsequently protecting people especially those with asthma and allergic rhinitis against COVID-19 [26,33,34]. This evidence concerns the gene ACE2 and asthma.